Ergoteles LLC Karuna Therapeutics, Inc. Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$176.32 - $240.22 $4.37 Million - $5.95 Million	24,781 Added 527.82%	29,476 $6.39 Million
Q1 2023 May 10, 2023	SELL	$161.33 - $204.36 $1.74 Million - $2.2 Million	-10,762 Reduced 69.63%	4,695 $852,000
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $2.96 Million - $3.66 Million	15,457 New	15,457 $3.04 Million
Q2 2022 Aug 12, 2022	SELL	$93.97 - $143.33 $787,562 - $1.2 Million	-8,381 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$98.9 - $132.37 $253,678 - $339,529	-2,565 Reduced 23.43%	8,381 $1.06 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $1.21 Million - $1.74 Million	10,946 New	10,946 $1.43 Million
Q4 2020 Feb 11, 2021	SELL	$75.23 - $109.23 $292,268 - $424,358	-3,885 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$71.31 - $109.74 $277,039 - $426,339	3,885 New	3,885 $300,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.